Carocell Bio is preclinical-stage biopharmaceutical company, focused on the development and commercialization of anti-inflammatory therapies and committed to bringing novel, life-changing treatments to patients with atopic dermatitis, ulcerative colitis and other inflammatory conditions. Carocell Bio believes its portfolio of products, which combine peptides and nanoparticle delivery technology, has the potential to deliver efficacy and safety benefits over existing standards of care and provide new approaches in the treatment of inflammation.
Carocell Bio Ltd is an ambitious company aiming to be revenue-generating within 3 years. We are driven to create new, more safe and effective treatments for serious inflammatory diseases that will make the world a better place and you can play a part in that process.
Carocell is seeking a total of $10m 'Series A' investment over the next 3 years to take the lead compound through to approved IND/CTA. The $10m dollars consists of:
Investing in our research at this relatively early stage means that your returns have the potential to be higher when products go to market. An equity share of the business now will have the potential to be far higher than at a later stage when much of the equity has been taken.
Government backed tax schemes such as SEIS and EIS are available to assist a business or individual wishing to invest in a company like Carocell Bio. Read more below.
Seed Enterprise Investment Schemes (SEIS) and Enterprise Investment Schemes (EIS) are schemes designed to encourage investment in small or medium sized companies. They offer tax relief to individual investors who buy new shares in the company. Small companies whilst being higher risk can grow very quickly and have the potential for large returns.
The Seed Enterprise Investment Scheme was set up in 2012 and is very similar to EIS but was designed for investing in even smaller companies, and providing even more generous tax breaks.
The maximum workforce and gross assets allowable under EIS are 250 staff and £15 million respectively, SEIS has lower limits of 50 staff and £200,000 gross assets. Businesses must also be less than two years old (there are no age restrictions under EIS).
SEIS tax breaks are as follows:
The UK government set up the Enterprise Investment Scheme in 1994 and offers a number of tax breaks to investors. Here are some key points and features:
If you invest through an angel investor network or an equity crowdfunding website, they should be able to help with the paperwork to access your EIS or SEIS benefits.
For more information about these schemes, please visit the HMRC website via links below:
If you would like to speak to us in detail about investing, tax benefits, donating or assisting us in any way at all, please contact us via the details below and we will get back to you as soon as possible.
UK: +44 (0) 20 3097 1979
US: +1 212 863 9902
Carocell Bio, Inc.
500 Delaware Avenue
©2018 Carocell Bio Ltd.
The BioHub at Alderley Park
Mereside, Alderley Park